BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results

  Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, reported financial results for its second quarter, ended December 31, 2021.

  February 3, 2022

   · 

  21 min read
• Business

  Lilly Reports Solid Fourth-Quarter and Full-Year 2021 Financial Results, Recent Late-Stage Pipeline Successes Set Up Next Wave of Innovative Medicines for Patients

  Eli Lilly and Company announced financial results for the fourth quarter and full year of 2021.

  February 3, 2022

   · 

  37 min read
• Business

  Nuvalent Appoints Emily Drabant Conley, PhD, to Board of Directors

  Nuvalent, Inc., a biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer, announced the appointment of Emily Drabant Conley, Ph.D., Chief Executive Officer of Federation Bio, to its Board of Directors.

  February 3, 2022

   · 

  6 min read
• Business

  BD REPORTS FIRST QUARTER FISCAL 2022 FINANCIAL RESULTS

  BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal year 2022, which ended December 31, 2021.

  February 3, 2022

   · 

  25 min read
• Business

  QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2022; INCREASES QUARTERLY DIVIDEND 6.5% TO $0.66 PER SHARE

  Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2021.

  February 3, 2022

   · 

  21 min read
• Business

  Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results

  Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2021.

  February 3, 2022

   · 

  43 min read
• Business

  Cardinal Health Reports Second Quarter Fiscal 2022 Results

  Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2022 revenues of $45.5 billion, an increase of 9% from the second quarter of last year.

  February 3, 2022

   · 

  34 min read
• Pharm Country

  Trevena to Present at the 2022 BIO CEO & Investor Conference

  Trevena, Inc. announced that Carrie Bourdow, President & CEO, will present a corporate overview at the BIO CEO & Investor Conference being held from February 14th - 17th, 2022.

  February 3, 2022

   · 

  1 min read
• Business

  Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates

  Mersana Therapeutics, Inc. announced a research collaboration and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover novel ADCs for three targets.

  February 3, 2022

   · 

  5 min read
• Pharm Country

  CytoSorbents Announces Participation in Two Upcoming Virtual Investor Conferences

  CytoSorbents Corporation announces management will participate in two upcoming virtual investor conferences.

  February 3, 2022

   · 

  5 min read